Breaking News: Exclusive Agreement Between NutraLife Biosciences Inc. (NLBS) and Owen J. Morgan Introduces Breakthrough Hemp Crop Extraction Technologies | Financial Buzz

Breaking News: Exclusive Agreement Between NutraLife Biosciences Inc. (NLBS) and Owen J. Morgan Introduces Breakthrough Hemp Crop Extraction Technologies

NutraLife Biosciences, Inc. (OTCQB: NLBS) announces that its subsidiary, PhytoChem Technologies, Inc. (“PhytoChem”) has entered an exclusive agreement with Owen J. Morgan, founder and CEO of Global Ecology Group (GEG) for the commercialization of the Ennea Processor (“Ennea”) in the United States of America, Latin America, the Caribbean, Central America, South America and Canada.

The Ennea is a unique system designed to extract bioactive compounds including cannabinoids from hemp and other plants. The Ennea process under the direction of Owen J. Morgan is a revolutionary method allowing for the extraction of components from whole plants while maintaining the cellular and fiber integrity of the plant. The Ennea’s process provides for the full recovery of biomass for further applications and eliminates the necessity of secondary recovery methods.

“Ennea is revolutionary, not only because of the results it produces but most importantly, because higher yields come with higher quality than ever witnessed in the industry,” says Owen J. Morgan. “Added to that, Ennea produces less waste, with a recovery of nearly 100% of all materials. That coupled with stunningly low energy requirements and complete extraction in one single pass makes Ennea the most environmentally responsible system ever developed for plant extraction. Ennea is highly scalable, mobile, and can be adapted to the needs of every user.”

Earlier this month, Mr. Morgan demonstrated and ran trials of the Ennea Process on a certified US grown hemp crop strain. The results, analyzed according to independent industry recognized standards for quantitative analysis (HPLC), confirm full spectrum extraction of all bioactive compounds including all terpenes. On the certified crop trials, Ennea extracted on average 30% higher yields than was previously believed to exist in the cannabinoid group.

Edgar Ward, NutraLife’s Chief Executive Officer and President, stated, “This cooperation leverages the synergy between GEG and NutraLife Biosciences and sets a new bar for the hemp crop extraction industry. The results witnessed after the trials performed by Mr. Morgan are even beyond our expectations. We believe that the Ennea system will completely change the extraction industry itself and, more importantly, it will bring higher quality hemp products to consumers.”

Through PhytoChem, NutraLife BioSciences plans to establish several Ennea Processing Plants across the United States of America to meet the demands of its partner growers for the 2019 growing season. PhytoChem estimates that the first Ennea facilities will be functional in October 2019 starting with four 800-liter systems.

About NutraLife BioSciences

Edgar Ward founded NutraLife in 2010 as NutraFuels, Inc. and since that time he has served as its Chief Executive Officer, President and Director. Under Mr. Ward’s direction, NutraLife’s revenues increased from $225,000 in 2016 to more than $3.7 million in 2018. NutraLife’s Coconut Creek manufacturing facility has been registered with the Food and Drug Administration, and its manufacturing facility has operated in accordance with the Good Manufacturing Processes Standard (GMP) for more than five years. NutraLife’s products are tested by its in-house laboratory chemists for strength, purity and contaminants such as heavy metals, pesticides, and solvents. NutraLife offers thirteen different core formulations which it modifies to meet the specifications of its private label customers. NutraLife provides approximately 50 different variations of its core formulations. NutraLife’s private label products include CBD infused oral sprays, tinctures, pet drops, pain balms, face creams, and nutraceutical oral spray products that support daily health and wellness uses.

About Global Ecology Group

The Global Ecology Group think tank (GEG) was formed in the United Kingdom in 2017 by Owen J. Morgan, its Founder to use science, technology and inspiration to develop progressive approaches for its foundation. GEG assists its partners in achieving their goals while meeting complex environmental challenges and improving current industry practices. GEG’s services are underpinned by the principles on which GEG was founded, a commitment to ecological integrity and its ability to solve complex challenges creatively and cost-effectively.

About Owen J. Morgan

Since 1990, Owen J. Morgan has founded and assisted companies that focused on finding real-world applications to complex environmental, social and business challenges across the globe. As an independent researcher and inventor, he is intrigued by developing practical solutions and systems for use in the extraction of natural bioactive compounds, environmental remediation and beneficial recovery of resources from nature and waste streams. He created and further developed many world recognized technologies that have been used and applied in a variety of applications. At the heart of Owen’s work is his steadfast belief that we can solve today’s problems while simultaneously helping to heal our planet.

Sponsored Content Release. Click for Full Disclosure

  • Sponsored Content Release, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For nutralife biosciences inc. financial and corporate news dissemination, has been compensated four thousand dollars by meridian ventures. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: